Literature DB >> 10945557

The safety of electrolytically induced hepatic necrosis in a pig model.

S A Wemyss-Holden1, P de la M Hall, G S Robertson, A R Dennison, P S Vanderzon, G J Maddern.   

Abstract

BACKGROUND: Electrolysis fulfils the criteria for an ideal treatment of patients with unresectable liver tumours. Previous studies in the rat and pig have shown that controlled necrosis can be safely produced by inserting platinum electrodes into normal liver' parenchyma and liver tumours. As with any new treatment it is mandatory to investigate the 'worst-case scenario' of inadvertent intravascular electrode placement in a large animal model before progressing to clinical trials.
METHODS: Under ultrasound control in six pigs, electrodes were inserted into, or immediately adjacent to, an hepatic vein. An electrolytic 'dose' of 100 C was then administered and the evolution of the lesion was monitored using ultrasound. Venous blood was collected before and during the electrolysis to evaluate potential acid/base disturbances and animals were closely monitored during electrolysis and during their recovery until a full autopsy was performed 4-7 days after treatment.
RESULTS: Gas bubbles were seen to enter the hepatic veins or interior vena cava during treatment in five of the six animals. There were no major complications as a consequence and all animals recovered and remained in a healthy state until they were killed. At autopsy one animal had complete thrombotic occlusion of the left hepatic vein. Otherwise, findings were normal.
CONCLUSION: In the clinical setting, due to the use of ultrasound to guide electrode placement into the centre of a tumour, the electrodes should rarely juxtapose an hepatic vein. Nevertheless, in this extreme situation, electrolysis is surprisingly safe with only one major vascular occlusion and no morbidity or mortality.

Entities:  

Mesh:

Year:  2000        PMID: 10945557     DOI: 10.1046/j.1440-1622.2000.01907.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  6 in total

1.  Thermal ablation for unresectable liver tumours, time to move forward?

Authors:  Gianpiero Gravante
Journal:  World J Gastrointest Surg       Date:  2010-01-27

2.  History, ethics, advantages and limitations of experimental models for hepatic ablation.

Authors:  Seok Ling Ong; Gianpiero Gravante; Matthew S Metcalfe; Ashley R Dennison
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

3.  Perductal electrolytic ablation of the porcine pancreas: a minimally invasive option-studies of morbidity and mortality.

Authors:  C P Morrison; F G Court; S A Wemyss-Holden; B D Teague; A Burrell; M Texler; M S Metcalfe; A R Dennison; G J Maddern
Journal:  Surg Endosc       Date:  2004-08-24       Impact factor: 4.584

4.  Patterns of histological changes following hepatic electrolytic ablation in an ex-vivo perfused model.

Authors:  Gianpiero Gravante; Seok Ling Ong; Kevin West; Angus McGregor; Guy J Maddern; Matthew S Metcalfe; David M Lloyd; Ashley R Dennison
Journal:  Pathol Oncol Res       Date:  2012-06-17       Impact factor: 3.201

5.  Electrolytic ablation of the rat pancreas: a feasibility trial.

Authors:  B G Fosh; J G Finch; A A Anthony; M Texler; G J Maddern
Journal:  BMC Gastroenterol       Date:  2001-09-06       Impact factor: 3.067

6.  Cell proliferation and apoptosis in rat mammary cancer after electrochemical treatment (EChT).

Authors:  H von Euler; K Stråhle; A Thörne; G Yongqing
Journal:  Bioelectrochemistry       Date:  2004-04       Impact factor: 5.373

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.